The Rising Prevalence of Neurological Disorders
A primary driver of the gamma knife market is the increasing global prevalence of neurological disorders, particularly brain tumors and brain metastases. With an aging global population, the incidence of these conditions is on the rise. Many brain tumors are located in areas that are difficult or impossible to reach with traditional surgery without causing significant damage to critical brain functions. Gamma Knife radiosurgery offers a precise and effective alternative in these cases, allowing for the delivery of a high dose of radiation directly to the target with exceptional accuracy.
Furthermore, advancements in cancer treatments have led to increased survival rates for primary cancers, which in turn has resulted in a higher number of patients developing brain metastases. Gamma Knife is an ideal treatment for these secondary tumors, especially when they are small and multiple, as it can treat several lesions in a single session. The growing need for non-invasive, targeted therapies for these complex and rising patient populations is a key factor fueling the market's expansion.